Dame Bridget Ogilvie obituary | Medical research

by Chief Editor

The Evolution of Genomics: From Mapping to Precision Medicine

The completion of the human genetic code was a watershed moment, but we are now moving from the era of genomic mapping to the era of genomic application. While the early days were about reading the “letters” of our DNA, the future lies in understanding the complex grammar of how those letters interact with our environment.

We are seeing a massive shift toward precision medicine. Instead of a “one size fits all” approach to healthcare, clinicians are increasingly using a patient’s unique genetic profile to tailor treatments, particularly in oncology and rare genetic disorders. This transition is being accelerated by the integration of Artificial Intelligence (AI), which can analyze vast datasets far beyond human capability.

From Instagram — related to Precision Medicine, Redefining Research Funding
Did you know? The cost of sequencing a human genome has plummeted from nearly $100 million in 2001 to under $600 today, making personalized genomic screening a viable reality for the general population.

Looking ahead, the trend is moving toward epigenetics—the study of how behaviors and environment cause changes that affect the way your genes work. This means the future of medicine won’t just be about the DNA you were born with, but how your life experiences “switch” certain genes on or off.

Redefining Research Funding: The Rise of Strategic Philanthropy

For decades, scientific funding relied on “little packets”—little, short-term grants that often forced researchers to play it safe to ensure continued funding. However, a new model of venture philanthropy is taking hold, favoring long-term, “flagship” enterprises that tackle systemic challenges.

This strategic shift allows for the creation of massive scientific infrastructures, similar to the early vision of the Wellcome Sanger Institute. By funding the infrastructure rather than just the experiment, philanthropic organizations are enabling “moonshot” projects that governments are often too risk-averse to support.

The Move Toward Open Science

The tension between private profit and public decent—once epitomized by the race between public consortia and private firms like Celera Genomics—is evolving. The future trend is Open Science. There is a growing global consensus that genomic data and fundamental medical research should be a public good, accessible to all researchers to accelerate the pace of discovery.

Pro Tip: For those looking to enter the field of biomedical research, focus on interdisciplinary skills. The most successful future researchers will be those who can bridge the gap between molecular biology, data science, and public policy.

Science Communication in the Age of Algorithmic Noise

As we move deeper into the 21st century, the challenge is no longer just a lack of information, but an overabundance of misinformation. The “anti-scientific” frenzies of the past have evolved into sophisticated, algorithmically-driven echo chambers.

Dr Dame Bridget Ogilvie, Biology: Changing the World Interview

The future of science communication is moving away from the “deficit model”—the idea that the public simply needs more facts—toward a model of scientific literacy and trust. Organizations like Sense about Science highlight the need for evidence-based frameworks that empower the public to evaluate claims critically.

We can expect to see a rise in “citizen science,” where the public is not just a consumer of scientific results but an active participant in data collection and analysis. This democratization of science is essential for rebuilding trust in institutional expertise.

The ‘One Health’ Frontier: Parasitology and Global Security

The study of parasitic worms and tropical medicine is no longer a niche field; it is central to the One Health approach. This philosophy recognizes that human health is inextricably linked to the health of animals and the shared environment.

The 'One Health' Frontier: Parasitology and Global Security
Dame Bridget Ogilvie Precision Medicine

With the increase in zoonotic spillovers—diseases jumping from animals to humans—the expertise once used to study sheep farm parasites is now critical for preventing the next pandemic. Future trends in this field include:

  • CRISPR-based Gene Drives: Engineering populations of disease-carrying insects (like mosquitoes) to eliminate malaria or dengue fever.
  • Synthetic Biology: Creating synthetic vaccines that can be deployed rapidly in response to emerging tropical threats.
  • Climate-Driven Epidemiology: Modeling how warming temperatures shift the geographical range of parasitic infections.

By integrating veterinary science with human medicine, researchers are creating a more holistic defense system against global health threats, ensuring that the “real-world problems” solved in the lab translate directly to field-level impact.

Frequently Asked Questions

What is the difference between genomics and precision medicine?
Genomics is the study of the entire genetic makeup of an organism. Precision medicine is the application of that knowledge to provide customized healthcare based on an individual’s genetic profile.

Why is “strategic philanthropy” better than traditional grants?
Strategic philanthropy focuses on long-term infrastructure and high-risk, high-reward “flagship” projects, whereas traditional grants are often short-term and fragmented, which can stifle breakthrough innovation.

What is the ‘One Health’ approach?
It is an integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals, and ecosystems, recognizing that they are all interdependent.

Join the Conversation

Do you believe genomic data should always be a public good, or is private ownership necessary to drive innovation? Share your thoughts in the comments below or subscribe to our newsletter for more insights into the future of science.

Subscribe for Updates

You may also like

Leave a Comment